Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Apex Healthcare Bhd's enterprise value is RM1,727.7 Mil.
Apex Healthcare Bhd's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was RM116.4 Mil. Therefore, Apex Healthcare Bhd's EV-to-EBITDA for today is 14.84.
The historical rank and industry rank for Apex Healthcare Bhd's EV-to-EBITDA or its related term are showing as below:
XKLS:7090'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.93 Med: 11.74 Max: 18.71
Current: 14.84
During the past 13 years, the highest EV-to-EBITDA of Apex Healthcare Bhd was 18.71. The lowest was 2.93. And the median was 11.74.
XKLS:7090's EV-to-EBITDA is not ranked
in the Medical Distribution industry.
Industry Median: 8.535
vs XKLS:7090: 14.84
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Apex Healthcare Bhd (XKLS:7090) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Apex Healthcare Bhd's PE Ratio (TTM) for today is calculated as:
Apex Healthcare Bhd's share price for today is RM2.61.
Apex Healthcare Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.092.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Apex Healthcare Bhd's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7090 vs MCK, COR, CAH: EV-to-EBITDA Comparison
For the Medical Distribution subindustry, Apex Healthcare Bhd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's EV-to-EBITDA falls into.
Apex Healthcare Bhd's current Enterprise Value is RM1,727.7 Mil.
Apex Healthcare Bhd's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM116.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Healthcare Bhd (XKLS:7090) has a EV-to-EBITDA of 14.84 as of Aug. 16, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Apex Healthcare Bhd. This is 26% above median its historical median of 11.74. Over the past decade, Apex Healthcare Bhd's EV-to-EBITDA has ranged from 2.93 to 18.71.
Is Apex Healthcare Bhd's EV-to-EBITDA too high?
Apex Healthcare Bhd's current EV-to-EBITDA of 14.84 is 26% above median its 10-year median of 11.74. Over the past 10 years, this metric has ranged from a low of 2.93 to a high of 18.71. The Medical Distribution industry median EV-to-EBITDA is 8.54. Apex Healthcare Bhd's value of 14.84 is 73.9% above this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's EV-to-EBITDA compare to MCK and COR?
Apex Healthcare Bhd's EV-to-EBITDA of 14.84 can be compared against companies in the Medical Distribution industry. The industry median EV-to-EBITDA is 8.54. Apex Healthcare Bhd's value of 14.84 is 73.9% above this benchmark. Historically, Apex Healthcare Bhd's own EV-to-EBITDA has ranged from 2.93 to 18.71 over the past decade. While the company's 10-year median is 11.74 vs. the industry median of 8.54, Apex Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.54, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current EV-to-EBITDA of 14.84 is 73.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Apex Healthcare Bhd. For the Medical Distribution industry, the median EV-to-EBITDA is 8.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current EV-to-EBITDA is 14.84, which is 26% above median its own 10-year median of 11.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current EV-to-EBITDA of 14.84. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current EV-to-EBITDA is 14.84, which is 26% above median its 10-year median of 11.74 and 73.9% above the Medical Distribution industry median of 8.54. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current EV-to-EBITDA is 14.84 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
EV-to-EBITDA: 14.84 (26% above median its 10-year median of 11.74)
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
Industry Position: 73.9% above the Medical Distribution median
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
